High incidence of veno-occlusive disease related to indicine N-oxide in the treatment of refractory adult acute leukemia.
Winton
E F
EF
McCue
P A
PA
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D001344:Autopsy; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000401:mortality; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000139:chemically induced; D011763:Pyrrolizidine Alkaloids / Q000009:adverse effects*; D014652:Vascular Diseases / Q000139:chemically induced*
D000972:Antineoplastic Agents, Phytogenic; D011763:Pyrrolizidine Alkaloids; C013095:indicine-N-oxide